James Dice, Pharm.D., BCPPS, FPPAG

Pharmacy Director

James Dice, Pharmacy

Undergraduate Studies

  • Bachelor of Science in Pharmacy, Philadelphia College of Pharmacy and Science

Pharmacy School

  • Doctor of Pharmacy, University of Tennessee Health Science Center College of Pharmacy

Residency

  • ASHP Accredited Residency in Hospital Pharmacy, Medical College of Virginia Hospitals
  • Pediatric Post-Pharm.D, LeBonheur Children’s Medical Center University of Tennessee Health Science Center

Clinical Interests

  • Neonatal pharmacology/therapeutics
  • Neonatal nutrition
  • Pediatric gastroenterology therapeutics
  • Pharmacy management
  • RSV and Palivizumab
  • Treatment of metabolic disorders
  • Enzyme replacement therapy

Honors and Awards

  • Three Lexi-Comp/PPAG Best Practice Awards, Pediatric Pharmacy Advocacy Group (2006, 2008, & 2010)
  • Fellow Pediatric Pharmacy Advocacy Group (FPPAG)
  • 2012 Richard A. Helms Award of Excellence in Pediatric Pharmacy Practice

Professional Affiliations

  • Pediatric Pharmacy Advocacy Group (PPAG) – Board of Directors, Executive Vice President, Chief of Operations Officer, Chairman of the Board
  • American Society of Health-System Pharmacists ( ASHP)
  • American Society of Parenteral and Enteral Nutrition (ASPEN)

Selected Publications

Dice JE, Bhatia J. Patient Ductus Arteriosus: An Overview. Journal of Pediatrics Pharmacology and Therapeutics 2007; 12: 138-146.

Dice JE. Physical Compatibility of Alprostadil with Commonly Used IV Solutions and Medications in the NICU. Journal of Pediatric Pharmacology and Therapeutics 2006; 11: 233-36.

Storms LE, Chicella MF, Toolan ER, Restaino I, Dice J. Sevelamer Use in Pediatric End Stage Renal Disease: A Case Report. Journal of Pediatric Pharmacology and Therapeutics 2004; 9: 145.

Chicella MF, Batres LA, Heesters MS, Dice JE. Prokinetic Drug Therapy in Children: A Review of Current Options. The Annals of Pharmacotherapy 2005; 39: 706-711.

Dice J ed. Handbook on Extemporaneous Formulations, American Society of Hospital Pharmacists, Bethesda, Maryland, 1987.


 

Michael Chicella, Pharm.D., BCPPS, FPPAG

Clinical Manager/ Residency Program Director / Pharmacy Clinical Specialist, Pediatric Intensive Care


Michael Chicella, PharmacyUndergraduate Studies

  • Bachelor of Science in Pharmacy, University of North Carolina School of Pharmacy

Pharmacy School

  • Doctor of Pharmacy, Campbell University School of Pharmacy

Residency

  • Pediatric Pharmacotherapy Specialty Residency, LeBonheur Children’s Medical Center University of Tennessee Health Science Center

Clinical Interests

  • Pediatric critical care medicine
  • Infectious disease

Honors and Awards

  • Fellow Pediatric Pharmacy Advocacy Group (FPPAG)
  • Two Lexi-Comp/PPAG Best Practice Awards, Pediatric Pharmacy Advocacy Group (2008 & 2010)
  • Faculty Member of the Year Award, Auburn University School of Pharmacy
  • Ross Award for Outstanding Effort in Pediatric Research

Professional Affiliations

  • Pediatric Pharmacy Advocacy Group (PPAG), Member, Board of Directors (2011-2014), Secretary (2018-present)
  • American College of Clinical Pharmacy (ACCP)
  • American Society of Health Systems Pharmacists (ASHP)

Selected Publications

Chicella MF, Krueger KP. Prospective Randomized Double-Blind Placebo Controlled Trial of Recombinant Human Erythropoietin Administration to Reduce Blood Transfusions in Anemic Pediatric Intensive Care Patients. Journal of Pediatric Pharmacology and Therapeutics 2006; 11: 101-106.

Storms LE, Chicella MF, Dice J. Sevelamer Therapy in Pediatric End-Stage Renal Disease. Pharmacotherapy 2006; 26: 410-413.

Chicella M, Partibhan A, Jansen P, Marlowe KF, Bencsath AF, Krueger K, Boerth R. Propylene Glycol Accumulation Associated with Continuous Infusion Lorazepam in Pediatric Intensive Care Patients. Critical Care Medicine 2002; 30: 2752-2756.

Hovinga C, Chicella M, Rose DF, Eades SK, Dalton J, Phelps SJ. Use of Intravenous Valproic Acid in Three Pediatric Patients with Nonconvulsive or Convulsive Status Epilepticus. Annals of Pharmacotherapy 1999; 33: 579-584.


 

Christina Hellauer, Pharm.D.

Pharmacy Clinical Specialist, Outpatient

Christina Hellauer, Pharmacy

Pharmacy School

  • Doctor of Pharmacy, University of Pittsburgh School of Pharmacy 

Residency

  • Pediatric Specialty Residency, Children’s Hospital of The King’s Daughters

Clinical Interests

  • Cystic fibrosis
  • Renal transplant
  • Spinal muscular atrophy (SMA)
  • RSV Prevention/ Synagis®

Professional Affiliations 

  • Pediatric Pharmacy Advocacy Group (PPAG)
  • American Society of Health-System Pharmacists (ASHP)
  • Virginia Society of Health-System Pharmacists (VSHP)

    Selected Publications

    Rozette NA, Hellauer CM, McKee CD, Vazifedan T, Gabriel CA, Dice JE, Yokois N. Evaluation of rapid versus standard infliximab infusions in the pediatric population. Inflamm Bowel Dis. 2018; 24(9): 2007-14.


     

    Jessica Price, Pharm.D.

    Pharmacy Clinical Specialist, Hematology/Oncology

    Jessica Price, PharmacyPharmacy School

    • Doctor of Pharmacy, University of Michigan, College of Pharmacy

    Residency

    • Pediatric Specialty Residency The Children’s Hospital, Denver, Colorado

    Clinical Interests

    • Hematology/Oncology
    • Fever and neutropenia
    • Tumor lysis pyndrome

    Professional Affiliations

    • Children's Oncology Group (COG)
    • American Society of Health-System Pharmacists (ASHP)
    • Pediatric Pharmacy Adovocacy Group (PPAG)

    Selected Publications

    Johnson CE, Hession JM, Price J. Stability of Norfloxacin as an Extemporaneously Compounded Oral Liquid. American Journal of Health-System Pharmacy 2001;58(7):577-9.

    RJ Mody, LM Krueger, J Price and DS Wechsler. Earlier Hospital Discharge in Selected, Low- Risk Pediatric Cancer Patients with Fever and Neutropenia. American Society of Clinical Oncology 1999.

    Jacobson PA, West NJ, Price J, Hutchinson RJ. Gentamicin and tobramycin pharmacokinetics in pediatric bone marrow transplant patients. Annals of Pharmacotherapy 1997 Oct; 31(10):1127-1131.


     

    Eloise D. Woodruff, Pharm.D., BCPPS

    Pharmacy Clinical Specialist, Neonatal Intensive Care 

    Eloise Woodruff, PharmacyUndergraduate Studies

    • Bachelor of Science in Pharmacy, Massachusetts College of Pharmacy and Allied Health Sciences

    Pharmacy School

    • Doctor of Pharmacy, Shenandoah University, Bernard J. Dunn School of Pharmacy

    Clinical Interests

    • Neonatal pain management
    • RSV Prevention/ Synagis® Notification Fax Program & RSV Clinic
    • Omegaven® (for parenteral nutrition associated liver disease), Compassionate Use Study PI
    • Parenteral nutrition
    • Antimicrobial stewardship

    Honors and Awards

    • Two Best Practice Awards, Pediatric Pharmacy Advocacy Group (PPAG, 2006 & 2010)
    • Lambda Kappa Sigma Distinguished Young Pharmacist (2001)
    • American Society of Association Executive (ASAE) Award of Excellence (2000)

    Professional Affiliations

    • Pediatric Pharmacy Advocacy Group (PPAG), 2014-2016 Neonatal Sig Chair and Education Committee, member
    • Virginia Society of Health-System Pharmacists (VSHP)
    • Phi Lambda Sigma Professional Leadership Society
    • Lambda Kappa Sigma Professional Fraternity
    • American Society of Health-System Pharmacists (ASHP)

    Selected Publications

    Chicella MF, Woodruff ED, Desai, M. A review of Candida prophylaxis in the neonatal intensive care population. Journal of Pediatric Pharmacotherapy and Therapeutics (JPPT) July 2011.

    Woodruff ED, Siegfried, BH.  Intravenous Omega-3 Fatty Acids for the Treatment of Parenteral Nutrition Associated Liver Disease (PNALD):  a case report of 20 NICU patients. Pediatric Pharmacy Advocacy Group.

    Christensen A, Woodruff ED, Tiffany K. An Evaluation of Caffeine for Apnea of Prematurity: Once Daily Verses Twice Daily Dosing. Pediatric Pharmacy Advocacy Group.

    Woodruff ED, Huber C, Dice J. CHKD Synagis® Notification Fax Program: A 5-year review of successful Respiratory Syncytial Virus Prophylaxis Identification. Pediatric Pharmacy Advocacy Group

    Woodruff ED, Chicella M, Tatum C, Dice J, Restaino I. The Use of an Amino Acid Dialysate in the Treatment of Pediatric ESRD Patients with Hypertriglyceridemia: A Case Report. Pediatric Pharmacy Advocacy Group


     

    Lisa M. Feagin, Pharm.D., BCPPS

    Pharmacy Clinical Specialist, Neonatal Intensive Care

    Lisa Feagin, Pharmacy

    Undergraduate Studies

    • Bachelor of Science in Cellular and Molecular Biology, University of North Carolina at Asheville

    Pharmacy School

    • Doctor of Pharmacy, University of North Carolina at Chapel Hill 

    Residency

    • Pediatric Specialty Residency, Children’s Hospital of The King’s Daughters

    Clinical Interests

    • Neonatal infectious disease
    • Respiratory distress syndrome
    • Apnea of prematurity
    • Neonatal abstinence syndrome
    • Iatrogenic withdrawal syndrome

    Professional Affiliations

    • Pediatric Pharmacy Advocacy Group (PPAG)
    • American Society of Health System Pharmacists (ASHP)
    • Kappa Epsilon Professional Pharmacy Fraternity

     

    Sarah Parsons, Pharm.D.

    Pharmacy Clinical Specialist, General Pediatrics

    Sarah Parsons, Pharmacy

    Undergraduate Studies

    • Bachelor of Science in Biology, Radford University

    Pharmacy School

    • Doctor of Pharmacy, Virginia Commonwealth University 

    Residency

    • HCA Health-System: Chippenham & Johnston Willis Hospital, Richmond Va.

    Clinical Interests

    • Cystic fibrosis
    • Infectious disease
    • Immunizations
    • Cerebral Palsy
    • Developmental medicine

    Professional Affiliations

    • Pediatric Pharmacy Advocacy Group (PPAG)
    • American Society of Health System Pharmacists (ASHP)
    • ACCP

     

    Kari Ausherman, Pharm.D.

    Emergency Department Pharmacist

    Kari Ausherman, Pharmacy

    Undergraduate Studies

    • Bachelor of Science in Pharmacy Studies, Northeastern University

    Pharmacy School

    • Doctor of Pharmacy, Northeastern University 

    Residency

    • Pediatric Specialty Residency, Children’s Hospital of The King’s Daughters

    Clinical Interests

    • Emergency medicine
    • Pediatric intensive care

    Professional Affiliations

    • Pediatric Pharmacy Advocacy Group (PPAG)

     

    Jennifer Hendricks, Pharm.D., BCPS

    Emergency Department Pharmacist

    Jennifer Hendricks, Pharmacy

    Undergraduate Studies

    • Associates in Pharmacy Technology and Pre-Pharmacy

    Pharmacy School

    • Doctor of Pharmacy, University of Wyoming 

    Clinical Interests

    • Emergency medicine
    • Critical care
    • Medication safety

    Professional Affiliations

    • Pediatric Pharmacy Advocacy Group (PPAG)
    • American Society of Health-System Pharmacists (ASHP)
    • American Pharmacists Association (APhA)

     


     

    Ashley Buksa, Pharm.D.

    Emergency Department Pharmacist

    Undergraduate Studies

    • Bachelor of Science in Pharmacy Studies, Samford University

    Pharmacy School

    • Doctor of Pharmacy, Samford University

    Residency

    • Pediatric Specialty Residency, Children’s Hospital of The King’s Daughters

    Clinical Interests

    • Emergency medicine
    • Critical care
    • RSV Prevention/Synagis®
    • Antimicrobial stewardship

    Professional Affiliations

    • Pediatric Pharmacy Advocacy Group (PPAG)
    • American Society of Health-System Pharmacists (ASHP)
    • Virginia Society of Health-System Pharmacists (VSHP)
    • American Pharmacists Association (APhA)

     

    Stephanie Crosby, Pharm.D., BCPS

    Emergency Department Pharmacist

    Undergraduate Studies

    • Bachelor of Science in Molecular and Cellular Biology with a Minor in Spanish at the University of Illinois at Urbana - Champaign

    Pharmacy School

    • University of Illinois at Chicago College of Pharmacy

    Residency

    • Temple University Health System

    Clinical Interests

    • Antimicrobial stewardship
    • Solid organ transplant
    • Emergency medicine

     Honors and Awards

    • CHKD Quality and Safety Award

     Professional Affiliations

    • American College of Clinical Pharmacy (ACCP)

    Selected Publications

    Crosby, S. and DeAngelo, M. (2017) Bench to Bedisde: Diagnostic Microbiology of the Clinician: The pharmacist role in antimicrobial stewardship and interpreting microbiology lab results. Nancy Khardori (Ed.) Boca Raton, FL : CRC Press/Taylor & Francis Group, 2017. 


     

    Stacey Lynn English, Pharm.D., MS

    Pharmacy Informatics Specialist

    Stacey English, PharmacyUndergraduate Studies

    • Bachelor of Science in Pharmaceutical Sciences, University of North Carolina at Chapel Hill

    Graduate Studies

    • Master of Science in Healthcare Informatics, Lipscomb University College of Pharmacy & Health Sciences

    Pharmacy School

    • Doctor of Pharmacy, University of North Carolina at Chapel Hill

    Residency

    • Pharmacy Practice, Sentara Martha Jefferson Hospital
    • Pharmacy Informatics, Lipscomb University College of Pharmacy & Health Science/Vanderbilt University Medical Center

    Clinical Interests

    • Clinical decision support
    • Process improvement
    • Medication safety
    • Antimicrobial stewardship
    • Automation management
    • Interoperability

     Professional Affiliations

    • American Society of Health Systems Pharmacists (ASHP)
    • Phi Delta Chi Professional Fraternity

     

    Elizabeth Rogers, Pharm.D., MPH, Cert. P Epi & P Vig

    Pharmacy Clinical Specialist, Medication Safety

    Undergraduate Studies

    • Bachelor of Science, Old Dominion University

    Graduate Studies

    • Master of Public Health, Eastern Virginia Medical School

    Pharmacy School

    • Doctor of Pharmacy, Shenandoah University, Bernard J. Dunn School of Pharmacy

    Fellowship

    • ASPPH/CDC Allan Rosenfield Global Health Fellowship, Lusaka, Zambia

    Clinical Interests

    • Medication safety
    • Quality improvement